⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
U.S. Patient Positioning and Support Aids Market Report 2026: Size, Share, Trends, and Forecast to 2033 | Aging Population and Surgical Growth Drive a $959.44 Million Opportunity
globenewswire.com
BAX
THC
HCA
AMN
SYK
RMD
EXPE
ISRG
SN
MASI
MDLZ
BIRD
BSX
GEHC
MDT
HOLX
EW
ZBH
DXCM
ABBV
BMY
MRNA
PFE
JNJ
GOOG
MSFT
AMZN
UNH
CVS
CI
EL
NVDA
AMD
INTC
QCOM
MU
WDC
SE
BABA
JD
BIDU
IQ
HTHT
NIO
LI
XPEV
RIVN
TSLA
CRSP
EDIT
BEAM
REGN
GILD
AMGN
VRTX
AZN
NVO
LLY
XRAY
COO
ICUI
GH
ALGN
TER
ADI
NXPI
ON
MCHP
SNPS
CDNS
AMAT
LRCX
KLAC
ASML
CAH
MCK
Opsera Relaunches as an AI-Native Software Factory for the Enterprise
globenewswire.com
CSCO
WDAY
HON
GH
ETN
Multi-Cancer Early Detection Market Size, Share, Competitive Landscape, and Forecast to 2034 | Liquid Biopsy and AI Drive 15.9% CAGR and a $5.85 Billion Opportunity
globenewswire.com
EXAS
GH
ILMN
Guardant Health belicht een ruime portfolio liquid biopsy-onderzoek tijdens ESMO Congress 2026
businesswire.com
GH
Guardant Health presenta l'ampio portafoglio di studi sulla biopsia liquida al Congresso ESMO 2026
businesswire.com
GH
Guardant Health präsentiert auf dem ESMO-Kongress 2026 sein umfangreiches Forschungsportfolio im Bereich der Flüssigbiopsie
businesswire.com
GH
Guardant Health destaca su amplia cartera de investigación en biopsia líquida en ESMO Congress 2026
businesswire.com
GH
Guardant Health dévoile son portefeuille impressionnant de recherches sur la biopsie liquide lors du congrès de l'ESMO 2026
businesswire.com
GH
TwinStrand Biosciences Announces Second U.S. Patent Trial and Appeal Board Decision Upholding All Claims of TwinStrand’s ‘127 Patent
businesswire.com
GH
Liquid Biopsy Market Research to Reach USD 27.42 Billion by 2035 as Cancer Blood Tests, AI Diagnostics and Precision Oncology Advance
globenewswire.com
GH
DGX
NTRA